Question · Q4 2025
Dylan Nassano asked for clarification on the Q4 underperformance due to manufacturing delays, specifically what changed since the last call, and sought an update on the new domestic cell supplier's capacity and payment terms.
Answer
President and CEO Julian Nebreda and CFO Ahmed Pasha explained that the Arizona enclosure facility's underperformance was due to underestimated staffing challenges, which are now largely resolved with increased personnel and optimized workflow, improving production from 1.5 to 5 enclosures per day. Ahmed Pasha added that the new cell supplier provides sufficient capacity for the next couple of years without material deposit commitments, securing future business.
Ask follow-up questions
Fintool can predict
FLNC's earnings beat/miss a week before the call